Navigation Links
Bug-Zapper: A dose of radiation may help knock out malaria
Date:11/8/2007

amber as well as sophisticated measuring equipment, NIST researchers mapped out the radiation dose at different parts of the chamber. They initially found there was a variation in dose within the chamber, but by suggesting that the manufacturer change the position of the chamber relative to the radiation source they were able to significantly reduce this variation in dose. This not only increases the speed of the process, but more importantly improves the quality of the process. To be safe for human trials all mosquitoes in the chamber must get their minimum dose of 150 gray.

The vaccine is currently being manufactured for the anticipated human clinical trials. NIST researchers will continue to be active in the manufacturing process by doing regularly scheduled quality-assurance tests that ensure the desired dose is being delivered to the mosquitoes.


'/>"/>

Contact: Ben Stein
bstein@nist.gov
301-975-3097
National Institute of Standards and Technology (NIST)
Source:Eurekalert

Page: 1 2

Related biology news :

1. A new radiation therapy treatment developed for head and neck cancer patients
2. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
3. Antioxidants could provide all-purpose radiation protection
4. Knocking out cell receptor may help block fat deposits in tissues, prevent weight gain
5. Binghamton University researchers investigate evolving malaria resistance
6. Advance in effort to fight malaria by tricking the mosquitos sense of smell
7. Progress Against Malaria: Developments on the Horizon
8. MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 ... products and services for gene function analysis and ... CRISPR Guide RNA (sgRNA) Knockout Library targeting all ... to specifically and permanently "knock out" a gene,s ... library provides a high throughput screening tool so ...
(Date:7/27/2015)... 2015   Zynx Health ™, the market ... solutions, today announced that its ZynxCarebook ™ ... Android smartphones and tablets. With this expansion, care ... use ZynxCarebook to securely exchange messages and share ... transitions to other care settings, and improve clinical ...
(Date:7/23/2015)... , July 23, 2015 Research ... addition of the "Global Outlook of the ... offering. The global biometrics market ... public and commercial applications owing to the uptake ... witness a transformation that enhances the growth of ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... MA -- Using ultrasound waves, MIT engineers have found ... drugs, making transdermal drug delivery more efficient. This technology ... needle-free vaccinations, according to the researchers. "This could ... cortisol, for example systemic drugs and proteins such ...
... strides in identifying genes that lead to an increased ... a continuum of social deficits, communication difficulties and cognitive ... these genetic risk factors impact the brain,s structure and ... developed. This led researchers at UCLA ...
... FARMINGTON, Conn., Sept. 13, 2012 /PRNewswire-iReach/ -- Global ... time offer on personalized medicine, next generation sequencing ... Pacific, a bio/pharmaceutical and life sciences industry analyst ... http://photos.prnewswire.com/prnh/20120913/CG74123 ) Personalized Medicine: Companies, Trends ...
Cached Biology News:Getting (drugs) under your skin 2Getting (drugs) under your skin 3Study reveals how common gene mutation affects kids with autism spectrum disorders 2Study reveals how common gene mutation affects kids with autism spectrum disorders 3How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment 2How to Differentiate Your Pharmaceutical Product in the Personalized Medicine Segment 3
(Date:7/30/2015)... Dallas, TX, USA (PRWEB) , ... July 30, ... ... nano and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. ... executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development activities ...
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... , July 30, 2015   Aratana Therapeutics, ... therapeutics company focused on the licensing, development and ... today announced that its strategic partner VetStem Biopharma, ... confirmation study of AT-016, an adipose-derived allogeneic stem ... treatment of osteoarthritis pain in dogs. ...
(Date:7/30/2015)... globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s online contractor ... in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Dallas, TX , ISN has additional offices in Calgary , ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3
... , INCLINE VILLAGE, Nev., Oct. 28 PDL BioPharma, ... it has priced a $300 million securitization transaction intended ... royalties. , Upon closing of the transaction, which is ... will sell to QHP Royalty Sub LLC ("QHP"), a ...
... , MINNEAPOLIS, Oct. 28 Techne Corporation,s (Nasdaq: ... September 30, 2009 decreased 6.4% to $26.8 million or ... $.74 per diluted share for the quarter ended September ... mainly due to foreign currency fluctuations, decreased consolidated net ...
... ... of work in September, health care industry continued growing, adding 19,000 new jobs. But ... ... healthcare and related fields continued to grow, even as more Americans found themselves out of ...
Cached Biology Technology:PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction 2PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 2Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 3Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 4Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 5Techne Corporation Releases Unaudited First Quarter Results For Fiscal Year 2010 6The MedZilla Report for September 2009 - Care Grows Again in September and - Surprisingly - Pharma Sales Jobs Up Too 2The MedZilla Report for September 2009 - Care Grows Again in September and - Surprisingly - Pharma Sales Jobs Up Too 3The MedZilla Report for September 2009 - Care Grows Again in September and - Surprisingly - Pharma Sales Jobs Up Too 4